Pharmacological brake-release of mRNA translation enhances cognitive memory
- PMID: 23741617
- PMCID: PMC3667625
- DOI: 10.7554/eLife.00498
Pharmacological brake-release of mRNA translation enhances cognitive memory
Abstract
Phosphorylation of the α-subunit of initiation factor 2 (eIF2) controls protein synthesis by a conserved mechanism. In metazoa, distinct stress conditions activate different eIF2α kinases (PERK, PKR, GCN2, and HRI) that converge on phosphorylating a unique serine in eIF2α. This collection of signaling pathways is termed the 'integrated stress response' (ISR). eIF2α phosphorylation diminishes protein synthesis, while allowing preferential translation of some mRNAs. Starting with a cell-based screen for inhibitors of PERK signaling, we identified a small molecule, named ISRIB, that potently (IC50 = 5 nM) reverses the effects of eIF2α phosphorylation. ISRIB reduces the viability of cells subjected to PERK-activation by chronic endoplasmic reticulum stress. eIF2α phosphorylation is implicated in memory consolidation. Remarkably, ISRIB-treated mice display significant enhancement in spatial and fear-associated learning. Thus, memory consolidation is inherently limited by the ISR, and ISRIB releases this brake. As such, ISRIB promises to contribute to our understanding and treatment of cognitive disorders. DOI:http://dx.doi.org/10.7554/eLife.00498.001.
Keywords: ATF4; Human; Mouse; Rat; eIF2; eIF2B; integrated stress response; memory consolidation; unfolded protein response.
Conflict of interest statement
NS: Reviewing Editor,
The other authors declare that no competing interests exist.
Figures
Comment in
-
Less translational control, more memory.Elife. 2013 May 28;2:e00895. doi: 10.7554/eLife.00895. Elife. 2013. PMID: 23741622 Free PMC article.
References
-
- Axten JM, Medina JR, Feng Y, Shu A, Romeril SP, Grant SW, et al. 2012. Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK). J Med Chem 55:7193–207 doi: 10.1021/jm300713s - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
